# TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent

> **NCT00292474** · PHASE2,PHASE3 · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 1326 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** percutaneous coronary intervention

## Key facts

- **NCT ID:** NCT00292474
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 1326 (ACTUAL)
- **Last updated:** 2008-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00292474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00292474, "TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00292474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*